{
  "symbol": "AVDL",
  "socialMediaRisk": {
    "hypeSusceptibility": true,
    "volatilityDrivenBy": ["biopharmaceutical sector", "Phase 3 clinical trials", "small-cap stock"],
    "riskScore": 7,
    "reason": "Avadel Pharmaceuticals operates in the biopharmaceutical sector, which is prone to speculation, especially with its product in Phase 3 trials. As a small-cap stock, it is more susceptible to retail-driven price movements."
  }
}